title: [Pharmacological and clinical profile of alogliptin benzoate (NESINA®)].
authors.affiliation: Takeuchi_Koji@takeda.co.jp
authors.forename: Koji
authors.initials: K
authors.lastname: Takeuchi
authors.forename: Tetsuya
authors.initials: T
authors.lastname: Fujita
authors.forename: Shinzo
authors.initials: S
authors.lastname: Hiroi
mesh_terms: D000328:Adult; D000818:Animals; D017322:Clinical Trials, Phase II as Topic; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004195:Disease Models, Animal; D015195:Drug Design; D052216:Glucagon-Like Peptide 1 / Q000097:blood; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use*; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D008297:Male; D010880:Piperidines / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use*; D051381:Rats; D014498:Uracil / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin; D010880:Piperidines; D014498:Uracil; D052216:Glucagon-Like Peptide 1; C520853:alogliptin